These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38265862)

  • 1. Understanding the Integrated Health Management System Policy in China From Multiple Perspectives: Systematic Review and Content Analysis.
    Yu Y; Wang S; You L
    J Med Internet Res; 2024 Jan; 26():e47197. PubMed ID: 38265862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding "Internet Plus Healthcare" in China: Policy Text Analysis.
    Yang F; Shu H; Zhang X
    J Med Internet Res; 2021 Jul; 23(7):e23779. PubMed ID: 34309581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of Policy Instruments on Integrated Care in China: Based on Documents Content Analysis.
    Yue X; Mu K; Liu L
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of assistive product policies in China from the perspective of the assistive product industry.
    Jiang H; Liu C; Wu X; Zhang H; Liu J
    Disabil Rehabil Assist Technol; 2023 Nov; 18(8):1266-1280. PubMed ID: 36368072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing national telemedicine policies in China from the perspective of policy instrument (1997-2020).
    Zhang W; He D; Wang G; Zhu C; Evans R
    Int J Med Inform; 2022 Oct; 166():104854. PubMed ID: 35981479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urban health: an example of a "health in all policies" approach in the context of SDGs implementation.
    Ramirez-Rubio O; Daher C; Fanjul G; Gascon M; Mueller N; Pajín L; Plasencia A; Rojas-Rueda D; Thondoo M; Nieuwenhuijsen MJ
    Global Health; 2019 Dec; 15(1):87. PubMed ID: 31856877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single or pluralistic? The game and balance of China's community governance policy tools.
    Xiang H; Bu Y; Wang X
    PLoS One; 2023; 18(11):e0288665. PubMed ID: 37972043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and reform of public health in China from 1949 to 2019.
    Wang L; Wang Z; Ma Q; Fang G; Yang J
    Global Health; 2019 Jul; 15(1):45. PubMed ID: 31266514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Differences, Dynamic Evolution and Convergence of Public Health Level in China.
    Li J; Xu M; Liu T; Zhang C
    Healthcare (Basel); 2023 May; 11(10):. PubMed ID: 37239745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating China's mental health policy on local-level promotion and implementation: a case study of Liuyang Municipality.
    Zhou W; Yu Y; Zhao X; Xiao S; Chen L
    BMC Public Health; 2019 Jan; 19(1):24. PubMed ID: 30616607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pathway of China's Integrated Delivery System: Based on the Analysis of the Medical Consortium Policies.
    Gao H; Du XL; Liao JZ; Xiang L
    Curr Med Sci; 2022 Dec; 42(6):1164-1171. PubMed ID: 36245032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bibliometric-Based Analytical Framework for the Study of Smart City Lifeforms in China.
    Xu Y; Li W; Tai J; Zhang C
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429480
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.